The Recall Desk
Agency classClass IIOur severity:SevereFDA (Drugs)·D-1277-2016·Announced 2016-07-20

Pharmakon Recalls Phenylephrine HCI Bags Due to Sterility Concerns

Pharmakon Pharmaceuticals is recalling Phenylephrine HCI 40mg/250 mL bags because the company cannot ensure the products are sterile.

The agency’s classification

FDA (Drugs): Class II

Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 4/5 (Severe).

The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a lack of assurance of sterility in an injectable medication, which poses a significant risk of serious injury or infection.

Plain-English summary

Pharmakon Pharmaceuticals, Inc. is recalling 10 units of Phenylephrine HCI 40mg/250 mL in 0.9% Sodium Chloride 250 mL bags. The recall is being conducted because the company lacks assurance of the sterility of the affected products. The specific product is identified by NDC 45183-0189-02 and is compounded by Pharmakon Pharmaceuticals in Noblesville, Indiana.

The affected products were distributed nationwide, including to VA and DOD facilities in California, Kentucky, Maryland, North Carolina, Oklahoma, Texas, and Virginia. The recall covers all sterile compounded products within their expiry dates. No specific lot numbers or expiration dates are listed in the source text.

Healthcare providers and patients should stop using the affected Phenylephrine HCI bags and contact Pharmakon Pharmaceuticals or their local FDA office for further instructions. Consumers should not use the product if they have any questions about its sterility or safety.

The recalled product

Product
Phenylephrine HCI 40mg/250 mL in 0.9% Sodium Chloride 250 mL bag, Rx Only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC 45183-0189-02
Manufacturer
Pharmakon Pharmaceuticals, Inc.
Category
Drug — Injectable Medication
Hazard
Affected units
10

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • All Sterile Compounded Products within Expiry

Distribution

Distributed nationwide across the United States.

The notice also names 7 states specifically:

Part of a larger recall action

This product is one of 88 recalled by Pharmakon Pharmaceuticals, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 88 products in this recall →

Related recalls

Same manufacturer · Pharmakon Pharmaceuticals, Inc.

See all →

Same hazard · sterility

See all →

Similar recalls